The lawsuit targets the period between October 28, 2024, and October 31, 2025. Plaintiffs allege that Regencell failed to disclose its vulnerability to market manipulation and the resulting volatility of its ordinary shares. These omissions purportedly exposed shareholders to significant financial risk and heightened regulatory scrutiny, leading to substantial losses when the realities of the company's position surfaced.
Investors who purchased shares during this window are not required to pay out-of-pocket fees to participate, as the case proceeds under a contingency fee arrangement. While a lawsuit is already active, the court requires any parties wishing to serve as lead plaintiff to file their motions by June 23, 2026. Until a class is formally certified, investors remain unrepresented unless they retain their own counsel. Those interested in joining the action or seeking more information can contact Phillip Kim at the Rosen Law Firm via their website or by calling 866-767-3653.

Comments (0)
No comments yet. Be the first!